• Analysis

Darkness is coming for us all.

  • Analysis

OJ shortages are possible in the wake of Hurricane Irma, and prices are expected to climb.

Biosimilars are copycat versions of brand-name drugs, intended to bring down drug spending.

America's central bank plans to start trimming down its $4.5 trillion balance sheet.

The Fed's balance sheet swelled to an unprecedented size as bank leaders attempted to turn the economy around.

The GOP is considering walking back some of its long-standing tax goals in a bid to bring Democrats on board.

  • Analysis

Trump promised to help the middle class. He can prove that with his tax plan.

The Foxconn deal could set a record for tax breaks given to a foreign company.

Future corporate inversions could reduce corporate tax receipts by $12 billion in 2027

Black people largely agree. The numbers don't.

  • Analysis

"We think everybody's putting on a show. And we forget the show actually has real consequences."

A USDA inspector general's report said that some “organic” shipments — legitimate or not — are fumigated with pesticides prohibited under USDA organic rules.

  • Analysis

The child-care debate in Washington is heating up.

  • Analysis

Women's pay is rising, but men's wages are flatlining

  • Perspective

The middle class's fortune hinges on a struggle between workers and investors, and that's terrifying.

  • Analysis

African Americans are the only racial group that has been left behind as the economy improved.

  • Analysis

Commutes keep getting longer, but there's a silver lining.

A Treasury spokesman said Mnuchin, a member of the National Security Council, wanted access to secure communications as he traveled abroad.

  • Analysis

What the latest Census Bureau data reveal about incomes outside the big cities.

Trump says taxes on the rich could go up. His treasury secretary says they'd mostly stay flat. Independent experts say they're both wrong.

Load More